The Hallmarks of Ageing: A Field Guide to Why We Get Old

A Framework That Changed Everything

By 2013, ageing research had accumulated decades of important findings but lacked a unifying framework. Scientists studying telomere shortening, researchers investigating mitochondrial dysfunction, and cell biologists characterizing senescent cells were all working on different pieces of the same puzzle but often speaking past each other. Then, in a single Cell paper that has since been cited over 30,000 times, five European researchers, Carlos Lopez-Otin, Maria Blasco, Linda Partridge, Manuel Serrano, and Guido Kroemer, proposed a framework that would reshape the entire field.

The hallmarks of ageing, originally nine and expanded to twelve in a 2023 update, are a set of cellular and molecular processes that collectively contribute to the loss of function and increased disease risk that we call ageing. The framework was built around three criteria for what qualifies as a hallmark: it should manifest during normal ageing, its experimental aggravation should accelerate ageing, and its experimental amelioration should slow ageing and thereby extend healthy lifespan. This last criterion is crucial: it means hallmarks are not just observations about what happens in old bodies, but actionable targets that might be therapeutically modified.

Understanding the hallmarks is increasingly relevant to anyone interested in personalized medicine or longevity, because modern biomarker panels, AI-powered health analysis, and emerging therapeutics are all, in one way or another, targeting specific hallmarks or measuring the degree to which they have progressed in an individual.

The Primary Hallmarks: Root Causes

Genomic Instability

Every cell in your body experiences tens of thousands of DNA lesions every day from oxidative damage, replication errors, ultraviolet radiation, and other sources. Sophisticated repair machinery continuously fixes most of this damage. But the repair systems are imperfect and become less efficient with age. The result is gradual accumulation of mutations, chromosomal rearrangements, and copy number variations across the genome. In somatic tissues, this genomic instability drives cells toward senescence or cancer. The connection between accumulated DNA damage and ageing is one of the most ancient and conserved relationships in biology, observed across species from yeast to mammals.

Telomere Attrition

Telomeres are the protective caps on the ends of chromosomes, composed of repetitive DNA sequences (TTAGGG in humans) bound by protective proteins. With each cell division, telomeres shorten because DNA polymerase cannot fully replicate the ends of linear chromosomes. When telomeres become critically short, cells enter replicative senescence or apoptosis. This process limits the number of times most human cells can divide, what Hayflick called the "replicative limit" in 1961. Telomere attrition is particularly relevant in rapidly dividing tissues like the gut, immune system, and skin. For more depth on this hallmark, see our dedicated article on telomeres and telomerase in ageing.

Epigenetic Alterations

The epigenome, the layer of chemical modifications on DNA and histones that controls gene expression, undergoes profound and reproducible changes with age. DNA methylation patterns drift in predictable ways that can be used as a biological clock. Histone modification patterns change. Chromatin organization becomes disordered. The result is inappropriate activation of genes that should be silenced and silencing of genes that should be active, contributing to loss of cell identity and function. This hallmark is particularly interesting because, unlike mutations in the DNA sequence itself, epigenetic changes are potentially reversible, which is why epigenetic reprogramming is one of the most exciting frontiers in longevity medicine.

The Antagonistic Hallmarks: Double-Edged Swords

Mitochondrial Dysfunction

Mitochondria, the organelles that generate most of a cell's ATP through oxidative phosphorylation, accumulate damage with age through multiple mechanisms. Mitochondrial DNA, which lacks the robust repair systems of nuclear DNA and sits in close proximity to reactive oxygen species generated by the electron transport chain, accumulates mutations over time. Mitochondrial dynamics (the balance of fusion and fission events) become dysregulated. The efficiency of electron transport chain complexes declines. The result is reduced energy production, increased oxidative stress, and activation of inflammatory pathways. Mitochondrial dysfunction is both caused by and contributes to virtually every other hallmark, making it a central node in the ageing network.

Cellular Senescence

As described in detail in our piece on senolytics and ageing cells, cellular senescence involves cells permanently withdrawing from the cell cycle while secreting an inflammatory cocktail called the SASP. Senescence is protective when acute and short-lived, suppressing tumor formation and aiding wound healing. It becomes pathological when senescent cells accumulate in tissues with age, creating a chronic inflammatory environment that disrupts organ function. The therapeutic targeting of this hallmark with senolytics has produced some of the most encouraging early clinical results in the longevity field.

Deregulated Nutrient Sensing

The mTOR, AMPK, and sirtuin pathways that sense nutrient and energy availability become dysregulated with age, typically in the direction of chronically elevated mTOR signaling. This suppresses autophagy, reduces stress resistance, and promotes the accumulation of cellular damage. As discussed in our article on caloric restriction and mTOR, interventions that reduce mTOR activity, including caloric restriction, fasting, and rapamycin, produce robust longevity benefits in model organisms and promising early results in humans.

The Integrative Hallmarks: Downstream Consequences

Stem Cell Exhaustion

The ability of tissues to regenerate and maintain themselves depends on pools of adult stem cells. With age, these stem cell pools shrink and become functionally impaired. Hematopoietic stem cells (which produce blood and immune cells), intestinal stem cells, muscle satellite cells, and neural stem cells all show age-related decline in numbers and functional capacity. This decline is not just a passive consequence of stem cell attrition: the niche environments that support stem cells also deteriorate with age, and many of the primary and antagonistic hallmarks directly impair stem cell function. Stem cell exhaustion manifests clinically as impaired wound healing, reduced immune function, muscle wasting, and reduced cognitive resilience.

Altered Intercellular Communication

Cells do not age in isolation. They communicate through hormones, growth factors, cytokines, extracellular vesicles, and direct cell-cell contacts, and these communication networks become disrupted with age. Inflammaging, the chronic low-grade inflammation of ageing, represents a particularly important form of altered communication that drives pathology across multiple organ systems. Studies of heterochronic parabiosis, in which the circulatory systems of young and old animals are surgically joined, demonstrated that factors in young blood can rejuvenate old tissues and vice versa, powerfully illustrating that systemic communication is a key driver of tissue ageing.

The 2023 Additions: Autophagy, Inflammation, and Dysbiosis

The 2023 revision to the hallmarks framework added three processes that had accumulated sufficient evidence over the preceding decade to qualify for hallmark status. Disabled macroautophagy captures the age-related decline in cellular recycling that was previously subsumed under other hallmarks but warrants independent recognition given its central role in proteostasis, organelle quality control, and many of the primary hallmarks. Chronic inflammation (inflammaging) was elevated from a downstream consequence to a hallmark in its own right, recognizing the extensive evidence that systemic inflammation is both a cause and driver of ageing, not merely a symptom. And dysbiosis, the age-related disruption of the gut microbiome's composition and function, was added given its profound effects on immune education, nutrient metabolism, and systemic inflammation.

Why the Hallmarks Framework Matters for Medicine

The hallmarks framework has done something that individual disease-focused research rarely achieves: it has provided a unified scientific rationale for treating ageing itself as a medical target. If you accept that the hallmarks are the root drivers of most chronic diseases of ageing, then a single intervention that significantly addresses even one or two hallmarks could theoretically reduce the risk of multiple diseases simultaneously. This is the logic behind trials of rapamycin, senolytics, and NAD+ precursors in otherwise healthy older adults: not treating any specific disease, but modifying the biological substrate that produces disease.

The framework also provides a rational basis for combining interventions that target different hallmarks. Senolytics targeting cellular senescence combined with mTOR inhibition targeting nutrient sensing combined with epigenetic reprogramming targeting epigenetic alterations could conceivably address a much larger fraction of the ageing process than any single approach. Whether such combinations are safe and effective in humans is what the next generation of clinical trials will determine, but the hallmarks framework is what makes those trials scientifically coherent rather than speculative fishing expeditions.